Costos directos e impacto sobre la morbimortalidad hospitalaria de eventos adversos prevenibles a medicamentos en una institución de tercer nivel de Bogotá

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biomedica

• Publication date

  2011-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.7705/BIOMEDICA.V31I3.320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

  2009cited by this paper
• Physician's guide to pharmacovigilance: terminology and causality assessment.

  2009cited by this paper
• Tercer Consenso de Granada sobre Problemas Relacionados con Medicamentos (PRM) y Resultados Negativos asociados a la Medicación (RNM)

  2007cited by this paper
• Tercer consenso de Granada sobre problemas relacionados con medicamentos (PRM) y resultados negativos asociados a la medicación (RNM)

  2007cited by this paper
• [Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward].

  2006cited by this paper
• Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I*

  2004cited by this paper
• Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting

  2004cited by this paper
• Frequency and Preventability of Adverse Drug Reactions in Paediatric Patients

  2004cited by this paper
• The cost of adverse drug reactions

  2003cited by this paper
• Nature of preventable adverse drug events in hospitals: a literature review.

  2003cited by this paper
• Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports.

  2002cited by this paper
• Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability

  2000cited by this paper
• Drug-Related Problems in Hospitalised Patients

  2000cited by this paper
• Adverse Drug Reactions: A Review of Relevant Factors

  2000cited by this paper
• Factors Associated with Preventability, Predictability, and Severity of Adverse Drug Reactions

  1999cited by this paper
• Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group.

  1999cited by this paper
• The Costs of Adverse Drug Events in Hospitalized Patients

  1997cited by this paper
• Drug-Related Morbidity and Mortality: A Cost-of-Illness Model

  1995cited by this paper
• Focusing on the preventability of adverse drug reactions.

  1992cited by this paper
• Preventability and severity assessment in reporting adverse drug reactions.

  1992cited by this paper

• Content validation of drug problem-oriented clinical record.

  2025cites this paper
• Factors associated with cost of adverse events in the intensive care unit: an economic evaluation performed in Bogotá, Colombia

  2024cites this paper
• Implementação de serviços de gerenciamento da terapia medicamentosa: revisão de literatura

  2023cites this paper
• Dos décadas de economía de la salud en Colombia

  2020cites this paper
• Reporting of statistical regression analyses in Biomédica: A critical assessment review

  2018cites this paper
• Costo del tratamiento farmacológico de las reacciones adversas graves por medicamentos en Cuba (2003-2013)

  2018cites this paper
• Interacciones farmacológicas entre warfarina y enoxaparina reportadas al Programa Distrital de Farmacovigilancia de Bogotá D. C. 2012-106

  2016cites this paper
• Errores relacionados con los medicamentos ocurridos en unidades de cuidados críticos y propuesta de mejora mediante la aplicación móvil de juegos educativos

  2015cites this paper
• The expenditure of computer-related worktime using clinical decision support systems in chronic pain therapy

  2015cites this paper
• Percepción entre médicos bogotanos del riesgo de reacciones adversas a grupos de medicamentos de uso común

  2014cites this paper
• Uso del Registro de Solicitudes de Medicamentos no Incluidos en el Listado de Medicamentos Esenciales como Nueva Fuente de Información en los Sistemas Nacionales de Farmacovigilancia.

  2013cites this paper